How much funding has Chronus Health raised?

Chronus Health has raised $22.0M in total funding, most recently a Series A round.

Who are Chronus Health's investors?

Chronus Health's investors include Tarsadia Capital.

Where is Chronus Health headquartered?

Chronus Health is headquartered in United States.

What industry is Chronus Health in?

Chronus Health operates in Healthcare.

Chronus Health

Portable, real-time blood testing for point-of-care settings

United States · $22.0M raised

Healthcare

Business Model: B2B
Website: chronushealth.com
Total Funding: $22.0M

Last Round: $22.0M Series AJan 2022
Rounds: 1

About

Chronus Health is a Fogarty Innovation company developing an electrical sensing-based, portable blood testing system designed to deliver comprehensive lab-quality results at the point of care in minutes. The platform uniquely combines microfluidics and semiconductor technologies to support cell counting, chemistry assays (electrolytes, small molecules, proteins), and immunoassays in a single device — capabilities that previously required centralized hospital laboratories. By enabling real-time blood diagnostics outside the hospital setting, Chronus Health aims to expand access to clinical-grade testing in emergency, urgent care, and resource-limited environments.

Summary

Chronus Health is a Healthcare company based in United States. It has raised $22.0M in total across 1 round, most recently a $22.0M Series A round in Jan 2022. Investors include Tarsadia Capital.